CDK6 and acute lymphoblastic leukemia: Cyclin-dependent kinase 6 (CDK6) inhibition by sodium butyrate or PD-0332991 decreased ALL cell growth in vitro, whereas the overexpression of pre-miR124a led to decreased tumorigenicity in an in vivo mouse model [97].